Latest Videos

The High Throughput Biomedicine unit at FIMM Technology Centre provides a wide range of biomedical high throughput assays.

This presentation will outline key issues in oncology biomarker testing and describe findings from a study of practices used by National Cancer Institute (NCI) designated cancer centers, the leading U.S. oncology institutions, for testing key biomarkers in three solid tumors - breast, gastroesophageal and non-small cell lung cancers.

The chip-system is capable of extracting miRNAs from tumor cell cultures, fresh frozen cells and archive material samples by on-chip gel electrophoresis.

Frank Vollmer discusses a technique using a single DNA oligonucleotide receptor and to follow its successive interactions with DNA molecules in a sample solution.

A lab-on-a-chip system called the "Fraunhofer ivD-platform" has been established which opens up the possibility for an on-site analysis at low costs.

Centrifugal microfluidics enables efficient miniaturization, integration, parallelization and automation of biochemical assays especially for Point-of-Care applications.

Present diagnostic procedures and therapeutic strategies solid tumours rely on the detection and targeting of specific marker molecules to classify the tumour and to design an efficient therapy.

Seth Crosby, Washington University School of Medicine, discusses both bench and informatic methods used to increase specificity in the apprehension of rare cfDNA alleles.

The diploid D genome species, Aegilops tauschii Coss. is source of allelic variation for hexaploid wheat, Triticum aestivum L and has provided numerous genes for resistance to diseases and insect pests.

Next generation DNA sequencing has revolutionised biology. However, the low cost and relative ease in generating draft genome assemblies has led to the production of many genome sequences of questionable quality or applicability.